Science Pool
Turning the Crank using a Hybrid Continuous Purification Platform
Watch on Demand Webinar - Assessing Transporter DDI Risk During Drug Discovery and Development
DoE Approach Applied to (TSWG) Platform: A Case Study
It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery
Quality Risk Management
Application of Design of Experiments in API Chemical Development
Rescuing the Unsolvable – A Case Study
Conversion of Fed-Batch to Continuous Bioprocess
Molecular Interactions Matter - Biophysical Screening for Early Drug Discovery
Involving clinicians in model-based designs with Non-DLT Adverse Events Integration: A safer approach to increase the performance of dose-escalation Phase I cancer trials
ICH M12 2024 vs FDA 2020 DDI Guidance - Exploring the Differences
Commercial Active Pharmaceutical Ingredient manufacturing challenges
Biomanufacturing cost reduction
Conversion of a Fed-Batch Process to a Continuous Bioprocess
Metabolic Characterization of a Perfusion Bioprocess
A High Productivity CHO Expression System for the Continuous Manufacturing of Antibodies” On-Demand Webinar
Continuous Biomanufacturing Arrives in Europe
Key considerations for API process development and optimization
OncoResponse chose Just-Evotec Biologics for the Phase 1 clinical manufacturing of their cancer-fighting antibody
Clinical proteomics: Supporting Drug Development and Biomarker Discovery
Tackling Autoimmune Disease with CAR iNK Cells
Achieving Continuous Manufacturing through Equipment Design
The Downstream Data Browser
The New ICH M12 Guideline – Harmony at Last for DDI Studies!
Delay with product Shelf-Life estimation? We can do it ASAP!
Real Life Evaluations of the User of Acoustic Tubers Under Normal Operations in a Compound Management Department
Leveraging Evotec Sample Management’s expertise and versatility for efficient integrated Research Projects: from compound acquisition to biological insights
Small molecule modulation of RNA splicing for drugging “undruggable” targets: taking advantage of Evotec’s high-throughput RT-qPCR platform
Combination of Affinity Selection Mass Spectrometry with Biophysical approaches to identify and characterize biomolecules binders
Development of a BRET assay for high throughput screening of Transcription Factor – DNA interaction modulators
Streamlining Hit Finding: Evotec's Integrated Approach to Sample Management and Hit ID
Continuous Biomanufacturing Reduces Environmental Impact
Fighting Tuberculosis by Targeting the Essential Enzyme 4’-Phosphopantetheinyl Transferase (PptT)
Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents
Redirecting Raltitrexed from Cancer Cell Thymidylate Synthesis to Mycobacterium Tuberculosis
Navigating IBD with Evotec: From discovery to cure
Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity
Navigating IBD with Evotec - From Discovery to Cure
J.CHO High Expression System for Continuous Manufacturing with Extraordinary Titers
Antifungal Drug Discovery Fact Sheet
Evotec Drug Discovery for ID
SARS-CoV2 2024
Hollow Fibre Infection Model 2024
Tuberculosis Capabilities 2024
Unlocking the Potential of Biomarkers: Enhancing Drug Development and Clinical Practice with a Focus on Aging
Addressing unmet challenges in CAR T cell therapeutics
Combatting solid tumours with iPSC-derived macrophage (iMAC) cell therapy
Unveiling Drug Targets with Precision: Leveraging Quantitative Proteomics
Functional Genomics for an enhanced Anti-Infective pipeline 2024
Anti-Fungal Capabilities 2024
AMR Capabilities 2024
Advances in Cardiotoxicity Prediction using Transcriptomics and Machine Learning
Find out Fast! Improved Efficiency in Endocrine Disrupter Screening of Chemicals
Establishing a New High Throughput Endocrine Disruptor Screening Panel
Development of a SP-TFF Step for Continuous End-to-End mAb Bioprocessing
New Early Stage Genotoxicity Screening Approach for Food Additives
New Genotoxicity Pre-screening Package for Food Additives
Drug Discovery Chemistry - Leveraging AI/ML DMTA engine
Proteomics and Metabolomics
Toxicogenomics and AI: A Breakthrough in DILI Prediction
Toxicogenomics and AI: A Breakthrough in DILI Prediction
Immuno-Oncology Therapeutic Area
Just - Evotec Biologics Introduction March 2024
Evotec DNA Damage Response
Evotec In vivo / Ex vivo Oncology and IO 2024
Evotec PanHunter Flyer
Oncology EVT801
Oncology Biomarkers 2024
Oncology iR&D 2024
Achieving Fully Continuous Downstream
J.POD® Toulouse: Revolutionizing Biologics Manufacturing in Europe
Continuous Biomanufacturing in Agile Production Facilities
How To Optimize Your Hit Identification Strategy – Evotec
ACS BIOT
Automated Patched Clamp Electrophysiology: Intracellular Exchange Assay
Implementation of SplintR ligation qPCR as novel bioanalytical method for tissues quantification of oligonucleotide therapeutics for the expansion of the Evotec oligonucleotide drug discovery platform
Webinar Slides: Deciphering the Clinical DDI Between Atazanavir and Rosuvastatin
Pipeline Co-creation Overview
Protein Science Solutions for Drug Discovery Overview
Data Driven Solutions for Drug Discovery - Protein Sciences
Hit and Lead ID Capabilities Presentation
Biotech's Rise in Externalization of Compound Management Service Whitepapers
Evotec (US) Sample Management Whitepaper
CRISPR Platform for Target Identification & Validation at Evotec Poster
Evotec (US) Sample Management Poster
RNA Epitranscriptomics as a Novel Therapeutic Target - Evotec and STORM Therapeutics Developing a METTL3 Inhibitor
BMWS 2024
American College of Toxicology (ACT)
Bio-Europe 2024
Integrated and Continuous Biomanufacturing (ICB) Conference
SLAS 2024 Sample Management Symposium
CPHI Milan
European Biomanufacturing Summit 2024
EUROTox 2024
ISSCR Annual Meeting 2024
JSOT (The 51st Annual Meeting of the Japanese Society of Toxicology)
Mining Omics Data for Drug Discovery
Deciphering the Immunopeptidome for Neoantigen Identification
Quantitative Proteomics for Target Deconvolution and Selectivity Profiling
Global Bioprocessing & Pharma 4.0 Summit
BioMed Israel
Pharma Manufacturing World Summit
A Candidate Antibody Drug for Prevention of Malaria
Virtual Roundtable on Continuous Manufacturing
Challenges in Biomanufacturing
Convergence Forum 2024
BioKorea 2024
London Biotechnology Show
34th ECCMID
35th Medicinal Chemistry in Eastern England
Science 2 Start Up
AACR Annual Meeting 2024
A Candidate Antibody Drug for Prevention of Malaria
A DoE Approach to Study the Influence of TSWG Process Parameters on the Characteristics of Granules and Tablets
Characterization of Compression Behavior of Co-Processed Excipient for Production of Orally Dispersable Tablets and of their Blends with Active Ingredient
A Study to Assess the Gastro-Resistance and Dissolution Rate of Enteric Coated Not-Banded Gelatin and HPMC Capsules
Impact of Tooling Size on the Heckel Profile and Derived Compressibility Parameters
Better and faster prediction of your drug product’s stability
Aerodynamic Particle Size Distribution
Presenting at BioProcess Int. Europe 2024
Presenting at BPI US West 2024
Virtual Roundtable Continuous Manufacturing
63rd SOT Annual Meeting and ToxExpo 2024
Bio-Europe Spring 2024
SLAS 2024
ADME/DMPK Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practice
American Biomanufacturing Summit 2024
Challenges in Biomanufacturing and How Just-Evotec Biologics Plans to Overcome Them
Optimizing Continuous Biomanufacturing Parameters Minimizes Costs
DCAT Week
Ireland Biomanufacturing Summit 2024
Improved Predictive Power in Cardiac Risk Assessment
Evotec’s Modular Target Identification System: PanOmics TargetID Framework
Benefits of a Customized Cell Line Development Program
Reducing Biopharmaceutical Manufacturing Costs in J.POD Facilities
Prediction of Functional and Structural Cardiotoxicants using hiPSC Cardiomyocytes
The Hollow Fibre Infection Model (HFIM), a novel in vitro model for developing anti-infective therapies
VEGFR-3 expression profiling by histology and biomarkers strategy to classify patient population for the selective VEGFR-3 inhibitor EVT801
NLSDays 2023
Drug Delivery to the Lungs (DDL) 2023
American College of Toxicology 44th Annual Meeting
European Bioanalysis Forum 16th Open Symposium
Biomanufacturing World Summit (BMWS)
ISPE Pharma 4.0
PEGS Lisbon
ASN Kidney Week 2023
European Society of Gene and Cell Therapy (ESGCT)
Oligonucleotide Therapeutics Society (OTS) Annual Meeting 2023
Society for Immunotherapy of Cancer 2023
Gene Therapy – An Introduction
GT – An Overview
GT – Capabilities
RNA/DNA/LNP capabilities
Genome Editing Capabilities
Non-AAV Viral Platform
Scientific Poster – AAV-based vectors
iPSC-based Cell Therapy Overview
Cell Therapy Manufacturing Overview
EvoGenes – Video
EVOgenes: Specialized Partner for Gene Therapy Development Factsheet
iPSC-based Cell Therapy Fact Sheet
The 35th GMP Symposium
Genotoxicity Risk Assessment During Lead Optimization Phase in Pharmaceutical Drug Development
Differentiated transcriptomic signatures detectable in primary human hepatocytes transduced by AAV-based vectors: A potential enabler for in vitro safety profiling
Discover the new Cyprotex e-Store
The New Cyprotex e-Store - ADME-Tox Services Now Available Online!
European Society of Gene and Cell Therapy (ESGCT)
IBIG Forum 2023
Norcal SOT Fall Symposium
Human PK and Dose Prediction for Small Molecules (PBSS)
Mitigating False Negatives in P-gp & BCRP Substrate Identification
A Spotlight on Aging Webinar series
Unlocking the Secrets of Healthy Aging: Prolonging Healthspan and Enhancing Quality of Life
Shining a Spotlight on the Mighty Mitochondria
BIO-EUROPE 2023
CPhI Barcelona 2023
AAPS PharmSci360 2023
iPSC-Derived Cell Therapies Summit 2023
How an Integrated, Continuous, Intensified Approach for Manufacturing Biologics Provides Productivity and Quality Benefits
Why early mAb Sequence Optimization can Improve Developability and Reduce Costs
Reducing biopharmaceutical manufacturing costs through continuous processing
Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity
57th Congress of the European Societies of Toxicology - EuroTox
QUOD & Evotec: An academia-industry partnership built on complementary strengths
Blood microsampling in cynomolgus monkey and evaluation of plasma PK parameters in comparison to conventional sampling
Important considerations for choosing the in vitro cell test system for correct identification of BCRP substrates
EVT801, a novel, selective VEGFR-3 inhibitor to fight solid tumors
High-content Imaging for the Detection of Compound Reactive Metabolite Formation and Cytotoxicity
Optimization of a Rat DRG Neurite Outgrowth Assay for Peripheral Neuropathy Prediction
Validation of a Serum-Free Approach to Facilitate the Development of High-Throughput Immunogenicity Screening Assays In Vitro
Measuring the Local Extracellular Action Potential (LEAP) with MEA to Enhance Prediction of Cardiotoxicity
High-Content Screening and High-Throughput RNA Sequencing using hiPSC-CMs for the Assessment of Functional and Structural Cardiotoxicity
Review Article – Studying the Right Transporter at the Right Time
25th North American ISSX Meeting
A Comprehensive Approach Using In Vitro Assays to Detect and Identify Mechanism of Mitochondrial Toxicity
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders
Filling a nick in NIK
SMR-DMPK
24th International Reid Bioanalytical Forum
Methods for Bioanalysis and Drug Metabolism course
